Discover the impact of inequalities in dementia care - Join the discussion on healthcare challenges đź§
If you can't view this email properly, take a look at our newsletter here
July 2024
Guest editor: Tim Watson | Director of Marketing & Communications
Together, we can transform dementia care and ensure fair access for all
The work of health economists extends beyond academic exercises; it can positively impact society by uncovering disparities and guiding better healthcare decisions.
At OHE, we have the privilege of conducting research that informs discussion in many challenging areas of healthcare policy. This month is no exception, as our latest report commissioned by Alzheimer’s Society, attests.
Dementia does not impact everyone equally, and our research reveals a staggering 110 disparities affecting those living with dementia and their carers. These inequalities span from diagnosis accessibility to financial burdens and participation in clinical trials.
Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, eloquently highlights the serious unfairness at play. The findings indicate how socio-economic status, geography, age, culture, and ethnicity can shape one's experience with dementia.
This report not only sheds light on these critical issues but also reveals a worrying lack of evidence and data about inequalities and their impact. To help address this, the Alzheimer’s Society has put out a call for a collective effort to bridge these gaps and offered funding for further research.
New OHE Publication
Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
110 inequalities affecting people living with dementia and their carers were identified across England, Wales, and Northern Ireland. With the expectation that 1 in 2 people will be impacted by dementia in their lifetime, the need for further research to inform future policy, research, and service interventions has never been more urgent.
Around the World in HTAs: United States – Making HTA Great Again
The US health care system is notable for its contrast with other high-income countries, lacking universal health coverage and characterised by a complex mix of private and public insurance. Unlike many other high-income countries, the US does not have a centralised national HTA process.
R&D For New Drugs To Tackle AMR Is A High Return Investment For All EU Member States
The threat of antibiotic resistance demands urgent action. Recent papers unveil how the EU can effectively incentivize the development of new antibiotics, projecting returns on investment and offering strategic policy reforms. Antibiotic resistance is a growing challenge. Previously OHE highlighted the need for R&D to develop new antibiotics.
Green Healthcare: Are We Asking the Right Questions?
4 September 2024, 15:00 BST, Virtual
Join us for an engaging webinar that explores the pressing need for the healthcare sector to address its impact on climate change while managing financial constraints. Our expert panel, featuring representatives from government, healthcare, industry, and academia, will delve into the dual challenges of managing climate change's impact on healthcare systems and reducing healthcare's environmental footprint. They will discuss innovative economic solutions required to achieve these goals without compromising financial sustainability. The climate crisis is a growing global concern, and identifying the right starting points is crucial.
